Phase 2 Obesity Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

This trial has several separate groups, each with different criteria. A person would need to meet the criteria for the specific group they are being considered for.

COMIDA group:

• People who identify as Mexican American or Mexican
• People who are seeking services at the Ventanilla de Salud (VDS) of the Mexican Consulate
• People who prefer to speak Spanish
• Adults aged 18 or older
• People whose Body Mass Index (BMI) is 25 or higher (a standard measure of body weight relative to height)
• People who agree to have conversations audio recorded

SANOS Focus Group:

• People who identify as Hispanic or Latino
• People who are seeking services at VDS or VDS Mobile
• People who prefer to speak Spanish
• Adults aged 18 or older
• People whose BMI is 25 or higher
• People who agree to have conversations audio recorded

SANOS Main Study (RCT):

• People who identify as Hispanic or Latino
• People who are seeking services at VDS or VDS Mobile
• People who prefer to speak Spanish
• Adults aged 18 or older
• People whose BMI is 25 or higher
• People who own a mobile phone that can receive text messages
• People who agree to have conversations audio recorded

Family COMIDA group:

• People who identify as Hispanic or Latino
• People who are seeking services at, or have previously used, VDS of the Mexican Consulate or VDS Mobile
• People who prefer to speak Spanish
• Adults aged 18 or older
• People who have at least one child under 18 living in the same household
• People who own a mobile phone that can receive text messages and are willing to receive 3 text messages per week for 3 months
• People who own an internet-connected device (such as a phone or tablet) that can be used for video calls (such as Zoom)

ROADmAP Main Study (RCT):

• Adults aged 21 or older
• People who are licensed taxi or for-hire vehicle (FHV) drivers working at least 35 hours per week
• People who have been driving for at least 6 months
• People who are seeking services at Health Fairs, or have previously used Health Fair services
• People who speak English, French, Bengali, or Spanish
• People whose BMI is 25 or higher (or 23 or higher for people of South Asian background, in line with World Health Organisation and American Diabetes Association guidelines)
• People who own a mobile phone that can receive text messages
• People who agree to have conversations audio recorded

ROADmAP Phase 2:

• Adults aged 21 or older
• People who either took part in the ROADmAP main study, or who are managers at a taxi garage, Uber, Lyft, or a driver services organisation or union
• People who agree to have conversations audio recorded

Who may not be able to join:

COMIDA group:

• People who will not be in the New York City area for the full study period (3–4 months)
• People who are pregnant, may be pregnant, or are currently breastfeeding
• People who have a chronic illness such as cancer, kidney disease, or liver disease (note: people with diabetes, lactose intolerance, or high blood pressure may still be considered)
• People who follow a medically restricted diet (such as a liquid-only diet)
• People who do not own a phone that can receive text messages, or who are not willing to receive text messages
• People whose mental health or cognitive condition, in the judgment of the consenting professional, may make it difficult to give informed consent or follow the study procedures
• People who already have a family member enrolled in the COMIDA study

SANOS Focus Group:

• People who are pregnant, may be pregnant, or are currently breastfeeding
• People who report having a chronic illness such as cancer, kidney disease, or liver disease (note: people with high blood pressure or diabetes may still be considered)
• People who follow a medically restricted diet (such as a liquid-only diet)
• People who have a household member who has already participated or agreed to participate in the study

SANOS Main Study (RCT):

• People who are pregnant, may be pregnant, or are currently breastfeeding, for the full study period (6 months)
• People who report having a chronic illness such as cancer, kidney disease, or liver disease (note: people with high blood pressure or diabetes may still be considered)
• People who currently follow a medically restricted diet (such as a liquid-only diet)
• People who have a household member who has already participated or agreed to participate
• People who have already taken part in this study previously
• People who will not be in the New York metropolitan area for the full study period (6 months)
• People who work for or with the Mexican Consulate, whether as an employee, collaborator, or volunteer

Family COMIDA group:

• People who are pregnant, may be pregnant, or are currently breastfeeding, for the full study period (3 months)
• People who will not be in the New York metropolitan area for the full study period (3 months)
• People who have a chronic illness such as cancer, kidney disease, or liver disease (note: people with diabetes, lactose intolerance, or high blood pressure may still be considered)
• People who follow a medically restricted diet (such as a liquid-only diet)
• People who already have a family member who participated in the COMIDA or SANOS studies
• People who have already taken part in this study previously
• People who work for or with the Mexican Consulate, whether as an employee, collaborator, or volunteer

ROADmAP Main Study (RCT):

• People who are pregnant, may be pregnant, or are currently breastfeeding, for the full study period (12 months)
• People who report having a chronic illness such as cancer, kidney disease, or liver disease that may affect their diet (note: people with high blood pressure or diabetes may still be considered)
• People who currently follow a medically restricted diet (such as a liquid-only diet)
• People who have a household member who has already participated or agreed to participate
• People who have already taken part in this study previously
• People who will not be in the New York metropolitan area for at least 6 months from when they join the study
• People who are currently taking, or have taken within the last 7 weeks, any medication used to treat obesity or to manage weight — including Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Saxenda, Victoza, Phentermine, Qsymia, Contrave, Plenity, Orlistat (Xenical), or any other GLP-1 receptor agonist or weight-related medication
• People who have previously had weight loss or bariatric surgery, or who are planning to have such surgery within the next 12 months

Important: Always verify eligibility with the trial site directly before applying.